A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
ImmunityBio, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
AbbVie
Eli Lilly and Company
NanOlogy, LLC
Rainier Therapeutics